Clinical Trials in New York State

Showing 16501-16520 of 17,167 trials

Study of XL999 in Patients With Previously Treated Ovarian Cancer

NCT00277290

This clinical trial is being conducted at multiple sites to evaluate the activity, safety, and tolerability of XL999 when given weekly to patients with ovarian cancer that has previously been treated with platinum-based chemotherapy. XL999 is a small molecule inhibitor of multiple kinases including VEGFR, PDGFR, FGFR, FLT-3, and Src, which are involved in tumor cell growth, formation of new blood vessels (angiogenesis), and metastasis.

Ovarian Cancer

Symphony Evolution, Inc.24 participantsStarted Jan 2006

Greenbrae, California, United States • Port Saint Lucie, Florida, United States • Chicago, Illinois, United States +6 more locations

COMPLETEDPhase 386 miles

ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)

NCT00091598

The primary objective is to determine the effect of ambrisentan on exercise capacity in subjects with PAH.

Pulmonary Hypertension

Gilead Sciences372 participantsStarted Jan 2004

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Los Angeles, California, United States +43 more locations

Study of XL999 in Patients With Previously Treated Ovarian Cancer

ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)

Find Trials by Condition in New York State

Safety Study of XL999 in Adults With Non-Small-Cell Lung Cancer

Study of XL784 in Patients With Albuminuria Due to Diabetic Nephropathy

Preimplantation Genetic Diagnosis for the Indication of Advanced Reproductive Age

Diabetes Control and Complications Trial (DCCT)

A Randomized, Placebo-Controlled Trial of BMS-275291 Given Daily for 12 Months to Women With Stage 1c-IIIA Breast Cancer Receiving Adjuvant Chemotherapy and/or Hormonal Therapy

Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations

Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Study of BMS-587101 in Patients With Moderate to Severe Psoriasis

Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma

Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3)

Extended Management and Measurement of Autism

Randomized Study of Human-Milk Based Nutrition Versus Formula in Premature Infants

Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.

A Phase I Study of BMS-275183 (Oral Taxane) Given on a Daily Schedule in Combination With Esomeprazole (Nexium) in Patients With Advanced Cancer

Multiple Ascending Dose Study of BMS-582949 in Patients With Stable Rheumatoid Arthritis on the Methotrexate Background

A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic Fibrosis

A Phase I Study of BMS-275183 Given on a Daily Schedule in Patients With Advanced Malignancies